Shareholding disclosure

IPConcept Luxembourg S.A

Declared position

4.55%

Threshold

Crossed upwards

Timeline

Published

24.10.2020

Transaction

20.10.2020

Voting rights breakdown

Voting rights acquired4.55%

Voting rights sold0%

Below threshold0%

Notice details

CategoryCollective investment vehicle

ExchangeXSWX

Notification ID

TCKAM00013

Beneficial owner

IPConcept Luxembourg S.A

Declared address

IPConcept (Luxembourg) S.A., L-14445 Luxembourg

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

IPConcept Luxembourg S.A

Kuros Biosciences AG24.10.2020TCKAM00013

Disclosure summary

IPConcept Luxembourg S.A disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 24.10.2020, at 4.55% of voting rights. Notice category: Collective investment vehicle.

Disclosed position

4.55%

Voting rights acquired

Voting rights acquired4.55%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

IPConcept Luxembourg S.A disclosed a holding in Kuros Biosciences AG, published on 24.10.2020.

Publication date24.10.2020

Transaction date20.10.2020

Issuing companyKuros Biosciences AG

Beneficial ownerIPConcept Luxembourg S.A

Declared addressIPConcept (Luxembourg) S.A., L-14445 Luxembourg

CategoryCollective investment vehicle

Voting rights acquired4.55%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTCKAM00013

Source: SIX Exchange Regulation · Publication date: 24.10.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open